Slope's inaugural State of Clinical Inventory and Sample Management survey gathered insights from 146 biopharma professionals on the impacts of inefficient, manual processes for managing clinical supply — lab kits, devices, ancillary supplies, and investigational product (IP) — and samples on budgets, timelines, data integrity, and patients. Download the survey report to learn more about these surprising findings.